Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine

Livrables

Clinical study report
Registration number of clinical trial in ClinicalTrials.gov and Swiss National Clinical Trials Portal
Clearances from ethic committees and regulatory authorities
Report on status of posting results in the study registry
Registration No. of Senegal clinical study in a WHO or ICMJE approved registry

Web based platform live

the web-based management platform will be built and operational within the first 6 months of the project (GSK). Then, the content will be regularly updated.

Publications

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Auteurs: Olga De Santis, Régine Audran, Emilie Pothin, Loane Warpelin-Decrausaz, Laure Vallotton, Grégoire Wuerzner, Camille Cochet, Daniel Estoppey, Viviane Steiner-Monard, Sophie Lonchampt, Anne-Christine Thierry, Carole Mayor, Robert T Bailer, Olivier Tshiani Mbaya, Yan Zhou, Aurélie Ploquin, Nancy J Sullivan, Barney S Graham, François Roman, Iris De Ryck, W Ripley Ballou, Marie Paule Kieny, Vasee M
Publié dans: The Lancet Infectious Diseases, Numéro 16/3, 2016, Page(s) 311-320, ISSN 1473-3099
Éditeur: The Lancet Publishing Group
DOI: 10.1016/S1473-3099(15)00486-7

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?

Auteurs: Teresa Lambe, Georgina Bowyer, Katie J Ewer
Publié dans: Philosophical Transactions of the Royal Society B: Biological Sciences, Numéro 372/1721, 2017, Page(s) 20160295, ISSN 0962-8436
Éditeur: Royal Society of London
DOI: 10.1098/rstb.2016.0295

Livrables

Publications

Partager cette page

Télécharger